Zhongquan Xin Selected Research

cecropin A

1/2020	Metabolic Profiling by UPLC-Orbitrap-MS/MS of Liver from C57BL/6 Mice with DSS-Induced Inflammatory Bowel Disease.
1/2019	Cecropin A Alleviates Inflammation Through Modulating the Gut Microbiota of C57BL/6 Mice With DSS-Induced IBD.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhongquan Xin Research Topics

Disease

3	Inflammation (Inflammations) 01/2020 - 01/2019
1	Weight Gain 03/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Diarrhea 01/2021
1	Colitis 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019
1	Body Weight (Weight, Body) 01/2019

Drug/Important Bio-Agent (IBA)

2	cecropin AIBA 01/2020 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2019
1	NucleotidesIBA 03/2021
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2021
1	InflammasomesIBA 01/2021
1	AsparagineIBA 01/2021
1	Aspartic Acid (Aspartate)FDA Link 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	CytokinesIBA 01/2020
1	Serine (L-Serine)FDA Link 01/2020
1	Gentamicins (Gentamicin)FDA LinkGeneric 01/2019
1	Antimicrobial PeptidesIBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019